SWOT Analysis for Cardiff Oncology Inc

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years - Nifty500
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months